The mutable collagenous tissue (MCT) of echinoderms possesses biological peculiarities that facilitate native collagen extraction and employment for biomedical applications such as regenerative purposes for the treatment of skin wounds. Strategies for skin regeneration have been developed and dermal substitutes have been used to cover the lesion to facilitate cell proliferation, although very little is known about the application of novel matrix obtained from marine collagen. From food waste we isolated eco-friendly collagen, naturally enriched with glycosaminoglycans, to produce an innovative marine-derived biomaterial assembled as a novel bi-layered skin substitute (Marine Collagen Dermal Template or MCDT). The present work carried out a preliminary experimental in vivo comparative analysis between the MCDT and Integra, one of the most widely used dermal templates for wound management, in a rat model of full-thickness skin wounds. Clinical, histological, and molecular evaluations showed that the MCDT might be a valuable tool in promoting and supporting skin wound healing: it is biocompatible, as no adverse reactions were observed, along with stimulating angiogenesis and the deposition of mature collagen. Therefore, the two dermal templates used in this study displayed similar biocompatibility and outcome with focus on full-thickness skin wounds, although a peculiar cellular behavior involving the angiogenesis process was observed for the MCDT.

Coping with a zero-waste, more sustainable economy represents the biggest challenge for food market nowadays. We have previously demonstrated that by applying smart multidisciplinary waste management strategies to purple sea urchin (Paracentrotus lividus) food waste, it is possible to obtain both a high biocompatible collagen to produce novel skin substitutes and potent antioxidant pigments, namely polyhydroxynapthoquinones (PHNQs). Herein, we have analyzed the biological activities of the PHNQs extract, composed of Spinochrome A and B, on human skin fibroblast cells to explore their future applicability in the treatment of non-healing skin wounds with the objective of overcoming the excessive oxidative stress that hinders wound tissue regeneration. Our results clearly demonstrate that the antioxidant activity of PHNQs is not restricted to their ability to scavenge reactive oxygen species; rather, it can be traced back to an upregulating effect on the expression of superoxide dismutase 1, one of the major components of the endogenous antioxidant enzymes defense system. In addition, the PHNQs extract, in combination with Antimycin A, displayed a synergistic pro-apoptotic effect, envisaging its possible employment against chemoresistance in cancer treatments. Overall, this study highlights the validity of a zero-waste approach in the seafood chain to obtain high-value products, which, in turn, may be exploited for different biomedical applications.

Preclinical investigations involving in vivo animal studies, are considered a crucial and mandatory step in pharmacological industry regulations. In recent years, as the ethical concerns associated with animal experimentation are becoming more relevant, substantial research efforts have been directed towards the development of novel in vitro methodological approaches aimed at minimizing the utilization of animals. Among those, three-dimensional (3D) cell culture systems have become one of the most promising substitutes for animal models. Skeletal muscle can be affected by genetic disorders and injuries. In this study, two types of 3D scaffolds (Coll and CollMA), prepared starting from a fibrillar collagen suspension extracted from sea urchin food waste, were used as platforms for the generation of 3D skeletal muscle tissue models. The scaffolds were cellularized with C2C12 myoblasts. As the culture period progressed, C2C12 cells gradually infiltrated and were viable throughout both scaffold types, establishing a multilayered cellular population. In the CollMA scaffold, the reciprocal Pax7/MyoD expression pattern suggests a progression of myoblasts towards myogenic commitment. Taken together, our results, although preliminary, suggest that sea urchin–derived collagen matrix represents a promising scaffold for skeletal muscle tissue engineering.

Collagen-based biomaterials are widely used in regenerative medicine, particularly in human clinical practice for musculoskeletal and dermal applications. In veterinary medicine, however, their adoption remains limited, mainly due to high costs, limited species-specific evidence, and the lack of standardized clinical protocols. Additionally, the need for extensive purification and traceability to meet regulatory safety requirements significantly impacts production costs and scalability. Marine-derived collagen (MDC), obtained from vertebrate (e.g., fish) and invertebrate (e.g., jellyfish and sponges) sources, has recently emerged as a promising alternative to mammalian-derived collagen. MDC can be sourced from seafood industry by-products, offering a more sustainable and potentially cost-effective solution. These materials present reduced biological risks, including negligible zoonotic transmission and absence of prion contamination, along with tunable structural and functional properties suitable for scaffold and hydrogel development. This scoping review, conducted in accordance with the PRISMA-ScR guidelines, provides a comparative analysis of mammalian- and marine-derived collagen-based scaffolds, focusing on their relevance for veterinary applications based on 61 sources selected from a systematic search of the PubMed and Scopus databases. Biological safety, functional performance, environmental sustainability, and economic accessibility are critically discussed. Particular attention is given to the potential of MDC to improve the accessibility, affordability, and sustainability of regenerative therapies in veterinary medicine.